Protection against dengue disease by synthetic nucleic acid antibody prophylaxis/immunotherapy
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Protection against dengue disease by synthetic nucleic acid antibody prophylaxis/immunotherapy
Authors
Keywords
-
Journal
Scientific Reports
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-07-29
DOI
10.1038/srep12616
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America
- (2015) Luis Villar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alarmin IL-33 Acts as an Immunoadjuvant to Enhance Antigen-Specific Tumor Immunity
- (2014) Daniel O. Villarreal et al. CANCER RESEARCH
- Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial
- (2014) Maria Rosario Capeding et al. LANCET
- Vectored immunoprophylaxis protects humanized mice from mucosal HIV transmission
- (2014) Alejandro B Balazs et al. NATURE MEDICINE
- Vectored Expression of the Broadly Neutralizing Antibody FI6 in Mouse Airway Provides Partial Protection against a New Avian Influenza A Virus, H7N9
- (2013) Maria P. Limberis et al. Clinical and Vaccine Immunology
- The global distribution and burden of dengue
- (2013) Samir Bhatt et al. NATURE
- Broad protection against influenza infection by vectored immunoprophylaxis in mice
- (2013) Alejandro B Balazs et al. NATURE BIOTECHNOLOGY
- Intranasal Antibody Gene Transfer in Mice and Ferrets Elicits Broad Protection Against Pandemic Influenza
- (2013) M. P. Limberis et al. Science Translational Medicine
- Optimized and enhanced DNA plasmid vector based in vivo construction of a neutralizing anti-HIV-1 envelope glycoprotein Fab
- (2013) Kar Muthumani et al. Human Vaccines & Immunotherapeutics
- The Economic Burden of Dengue
- (2012) Duane J. Gubler AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
- (2012) Arunee Sabchareon et al. LANCET
- Electroporation delivery of DNA vaccines: prospects for success
- (2011) Niranjan Y Sardesai et al. CURRENT OPINION IN IMMUNOLOGY
- Antibody-based protection against HIV infection by vectored immunoprophylaxis
- (2011) Alejandro B. Balazs et al. NATURE
- Enhanced Infection of Liver Sinusoidal Endothelial Cells in a Mouse Model of Antibody-Induced Severe Dengue Disease
- (2010) Raphaël M. Zellweger et al. Cell Host & Microbe
- The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity
- (2010) Martina Beltramello et al. Cell Host & Microbe
- Structure and Function Analysis of Therapeutic Monoclonal Antibodies against Dengue Virus Type 2
- (2010) S. Sukupolvi-Petty et al. JOURNAL OF VIROLOGY
- The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1
- (2010) Bimmi Shrestha et al. PLoS Pathogens
- Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys
- (2009) Philip R Johnson et al. NATURE MEDICINE
- DNA vaccines: ready for prime time?
- (2008) Michele A. Kutzler et al. NATURE REVIEWS GENETICS
- Antibodies play a greater role than immune cells in heterologous protection against secondary dengue virus infection in a mouse model
- (2008) Jennifer L. Kyle et al. VIROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started